TechCrunch’s September 26, 2024 roundup highlighted nine companies from Y Combinator’s Summer 2024 Demo Day 2. The selection was not an official YC ranking: it was a snapshot of startups spanning AI software, chips, biotech, freight, weather modeling, drones and traffic systems. Its most striking numbers came from company-reported early tests, not independently validated results.
What the Demo Day 2 roundup covered
Marina Temkin’s TechCrunch roundup, published September 26, 2024, selected nine startups from the second Demo Day for YC’s Summer 2024 cohort. The companies addressed different problems and were at different stages, so the article did not provide a standardized comparison of results, deployments or product maturity.
For a finance-minded reader, the useful distinction is between what a company was reported to be building, what it claimed to have tested, and what it said was already in use. Those are different kinds of evidence; a reported deal or deployment is not the same as a measured product outcome.
The nine startups, by what they were building
AI and software
- Entangl: TechCrunch described software that detects errors in engineering projects, proposes fixes and can implement them. The report said the startup had spoken with Amazon CEO Andy Jassy about automating data-center verification and had deals with AWS and Vodafone. These are details reported in 2024; they were not independently verified in the article.
- LedgerUp: An AI bookkeeping service for startups. Its described functions included categorizing transactions, identifying missed discounts and credits, and managing invoices and taxes.
- OrgOrg: A suite of productivity apps intended for growing organizations. The article also relayed founder Wayne Crosby’s account that an earlier YC company he founded was later sold to Google and became Google Slides.
Chips and biotech
- Exa Laboratories: The company was presented as developing energy-efficient AI chips that could be configured in software for different models. TechCrunch said the company’s early tests purportedly found its chips nearly 28 times more efficient than Nvidia H100s. That was a company test result as reported in 2024, not an independently established benchmark. The article said Exa hoped to have chips ready for use by early 2025; that was a forecast at the time, not confirmation of later availability. A YC profile later surfaced under the name Zettascale Computing, associated with Exa’s launch.
- Kopra Bio: An experimental autoimmune therapy intended to kill cancer. The founders’ animal-test claims, as reported by TechCrunch, said most animals receiving the experimental treatment were still alive after 250 days, while animals receiving an FDA-approved drug died in 50 days. This is a preclinical animal comparison, not evidence of efficacy or safety in people.
Logistics, weather, drones and traffic
- Oway: TechCrunch described the service as “carpooling for freight,” allowing smaller businesses to share truck capacity. YC’s company profile describes coordination of shipments using unused truck space along existing routes.
- Silurian: The startup was described as developing a foundational weather-prediction model, with founders who had worked on Microsoft Research’s Aurora. TechCrunch reported the founders’ claim that their model outperformed Aurora; the claim is not validated by YC’s later description. YC’s profile describes foundation models for simulating Earth, starting with weather, and names energy, insurance, agriculture and logistics as sectors served.
- Theseus: The company was presented as building drones designed to keep operating despite jamming. “Unjammable” was shorthand for the company’s claimed capability, not an absolute technical guarantee.
- XTraffic: A system using smart traffic lights to reduce congestion and accidents. The company said it was operating in several Texas cities, but the roundup did not name those cities or report quantified outcomes.
How to interpret the headline claims
The roundup’s most dramatic figures should be read with their evidence type and date attached. Exa’s nearly 28-times efficiency comparison came from early company tests and was qualified as purported. Kopra Bio’s 250-day-versus-50-day comparison concerned animals in founders’ reported tests. Neither figure was presented as an independently published study, and the animal result does not establish a human clinical outcome.
The Tool Desk
Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →#1 Best Overall
Other claims describe commercial activity rather than measured performance: Entangl’s reported customer arrangements and XTraffic’s reported deployments are not accompanied by independent audits or comparable impact metrics in the roundup. Likewise, a founder-reported comparison between Silurian and Aurora is not an independent model evaluation.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What the 2024 snapshot can—and cannot—tell you
The nine selections show the range of ideas at that YC Demo Day, not a ranked forecast of which companies would succeed. The roundup offers no common scorecard for customer traction, technical performance, revenue or deployment scale. Its claims and forecasts belong to the companies’ 2024 launch period; the later YC profiles add descriptions for Oway and Silurian and identify an Exa-related listing under Zettascale Computing, but they do not establish that every 2024 claim was proven or that each startup remains active today.
To compare these companies responsibly, separate the customer problem and intended product from maturity and evidence: a preclinical animal test, an early chip benchmark, a company-reported commercial deal and a claimed city deployment answer different questions. The original roundup is best treated as a historical introduction to nine startups, not as current diligence or a basis for investment decisions.
Quick Recap
Best Value
- Built for the startup founder survivor who’s been through the grind, this piece honors the founder comeback story and the mental strength to keep going.
- Whether it’s a co-founder survival moment or a gift for a founder who overcame burnout, this startup grind survivor piece speaks to healing and resilience.
- Hardcover journal with 240 line-ruled pages (120 sheets)
- Built-in elastic closure and ribbon bookmark
- Includes an expandable inner storage pocket and a pen holder
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Repair Windows errors before they cause bigger problemsFix Now →
